Zalicus (ZLCS)
Zalicus Revenue Growth: 82.53%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ZLCS Revenue Growth Rankings
| Overall | 95th percentile | 184 of 4363 |
| Sector | 89th percentile | 49 of 457 in Healthcare |
| Industry | 74th percentile | 32 of 126 in Biotechnology |
ZLCS Revenue Growth Range, Past 5 Years
| Minimum | -96.92% | Mar 2011 |
| Maximum | 1470% | Mar 2010 |
| Average | 82.64% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these ZLCS related companies
ZLCS News
$ZLCS Mentioned more than normal on StockTwits - Currently at 2 x average daily social activity
about 18 hours ago by TradeIdeasQuant
about 18 hours ago by TradeIdeasQuant
finally added $ZLCS...been window shopping for a while w/ this one.
about 18 hours ago by casualtrader
about 18 hours ago by casualtrader
$ZLCS Vanguard holdings of over 1 miliion shares is a strong indicator of good things to come....
about 20 hours ago by jeremykillmer
about 20 hours ago by jeremykillmer
RT @ACInvestorBlog $ZLCS looks like it wants to clear the $1 price level very soon
about 2 days ago by gabbs
about 2 days ago by gabbs
$ZLCS http://stks.co/400Q Looks good here with plenty of room to run to the next resistance at $1.01
about 5 days ago by ACInvestorBlog
about 5 days ago by ACInvestorBlog
@irishdroog Dang it...I wish someone had paid a little attention to my question 2 days ago!!! $ZLCS is going how high?
about 7 days ago by irishdroog
about 7 days ago by irishdroog
$ZLCS Mentioned more than normal on StockTwits - Currently at 5 x average daily social activity
about 7 days ago by TradeIdeasQuant
about 7 days ago by TradeIdeasQuant
$ZLCS http://stks.co/3zca looks very interesting here... Bullish MACD cross
about 7 days ago by ACInvestorBlog
about 7 days ago by ACInvestorBlog
$ZLCS and KV/A are having a respectable day. I still believe that in the near future, $ZLCS is going to skyrocket.
about 7 days ago by Flynt2012
about 7 days ago by Flynt2012
Ugh...meant $SVU...Can't decide which to buy on weakness $ZLCS or $SUV. Which is most likely to rally the strongest?
about 9 days ago by irishdroog
about 9 days ago by irishdroog
Can't decide which to buy on weakness $ZLCS or $SUV. Which is most likely to rally the strongest?
about 9 days ago by irishdroog
about 9 days ago by irishdroog
@markf @ANDISIK any other biotech ideas? Long $AIS, looking to initiate long position $ZLCS. Thoughts?
about 9 days ago by casualtrader
about 9 days ago by casualtrader
Canaccord Genuity Reiterates a 'Buy' on Zalicus (ZLCS); Q1 Update: Synavive Phase 2b Enrollment Complete
May 15, 8:46AM Street Insider
May 15, 8:46AM Street Insider
Zalicus Completes Patient Enrollment in Phase 2b Clinical Trial of Synavive in Rheumatoid Arthritis
Apr 30, 7:30AM Business Wire
Apr 30, 7:30AM Business Wire
Zalicus Discovers Novel Multi-Target Mechanism for the Treatment of Multiple Myeloma
Apr 05, 8:00AM Business Wire
Apr 05, 8:00AM Business Wire
Zalicus Reports Financial Results for the Fourth Quarter and Year End 2011
Mar 07, 7:30AM Business Wire
Mar 07, 7:30AM Business Wire
Zalicus Successfully Completes Phase 1 Clinical Study with Reformulated Z160
Mar 05, 8:03AM Benzinga
Mar 05, 8:03AM Benzinga
Zalicus to Present at Cowen and Company 32nd Annual Health Care Conference
Feb 29, 4:30PM Business Wire
Feb 29, 4:30PM Business Wire
Zalicus and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain
Feb 09, 4:30PM Business Wire
Feb 09, 4:30PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ZLCS | 0.95 | -0.01 | -1.04% | 99.52M |
| ZLC | 2.34 | -0.12 | -4.88% | 75.37M |
| ZIXI | 2.46 | -0.09 | -3.53% | 154.68M |
| ZIPR | 1.49 | +0.07 | +4.93% | 30.63M |
| ZIP | 10.75 | +0.40 | +3.86% | 426.45M |
| ZIOP | 5.14 | +0.12 | +2.39% | 408.48M |
| ZION | 18.51 | -0.52 | -2.73% | 3.504B |
| ZINC | 8.86 | -0.17 | -1.88% | 387.36M |
| ZIGO | 16.58 | -0.33 | -1.95% | 301.26M |
| ZHNE | 0.84 | -0.06 | -6.67% | 25.91M |